📺 In the latest episode of #OptimumTV, Michael Karl Bauer, Partner at Novo Holdings Venture Investments, explains why the investor was so keen on #British #biotech Myricx Bio, a spin-out from Imperial College London and The Francis Crick Institute. Myricx has concluded a staggering £90m Series A round, led by Novo Holdings, to develop #ADCs which use an entirely new class of payload based on its NMT-inhibitor technology.
Optimum Strategic Communications
Public Relations and Communications Services
London, London 1,621 followers
International Strategic Healthcare Communications
About us
Optimum is an international strategic communications firm specialising in investor relations, corporate and financial communications. Our team of healthcare specialists, based in London and New York, have worked together for many years. Our first-hand experience of analysing, investing and writing about healthcare companies uniquely positions us when advising our clients on building a compelling investment story. Subscribe to our Optimum Perspectives Podcast, where we host industry leaders, and highlight the latest innovation and developments in life sciences. Listen here now: https://www.optimumcomms.com/podcast/
- Website
-
http://www.optimumcomms.com
External link for Optimum Strategic Communications
- Industry
- Public Relations and Communications Services
- Company size
- 11-50 employees
- Headquarters
- London, London
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Investor Relations, Financial Communications, Media Relations, Healthcare, Life Sciences, Corporate Communications, and Public Relations
Locations
-
Primary
8 Devonshire Square
London, London EC2M 4YP, GB
Employees at Optimum Strategic Communications
Updates
-
From a £90 million Series A #financing to a pill to boost #ART success, here’s what Optimum’s clients have been up to this week! #OptimumStrategicCommunications #biotech #LifeSciences
-
We are incredibly sad at the passing of our friend Lisa Burns, Founder and CEO of Burns McClellan Inc.. We worked closely with Lisa for several years and loved her passion, knowledge and enthusiasm. She will be greatly missed. We extend our deepest condolences to her family and the team at BM at this very difficult time.
May her memory be a blessing. https://lnkd.in/epNFx-zg
-
-
From plant-based fungi food to an #award to develop a potential disease-modifying therapy for #Parkinson’s disease, here’s what our clients have been up to this week #OptimumStrategicCommunications #LifeSciences
Novo Holdings invests in MATR Foods’ expansion within plant-based fungi food
Optimum Strategic Communications on LinkedIn
-
Great to see our client STORM Therapeutics Limited and Matthew Fyfe at #ONHelix24 today where he shared his experience from the One Nucleus Boston Bootcamp earlier this year. Matthew detailed his learnings and how the UK differs from the US, particularly in terms of funding and investment in the #biotech infrastructure in Massachusetts, Boston.
-
-
Amir Hefni presented Resolution Therapeutics as ‘a company to watch’ detailing the innovative modality the Company is using at #ONHelix2024. Amir also took part in the ‘New Horizons for Therapeutic Modalities’ #panel discussing the importance of early conversations to speed up optimisation with CROs and with the FDA/MHRA. Very exciting things to come for our client, whose novel approach in developing macrophage cell therapies aims to treat #diseases characterised by life-threatening #inflammatory organ diseases.
-
-
One Nucleus' #OnHelix conference is this Thursday! Optimum Strategic Communications is a proud supporter of One Nucleus events and is happy to share an exclusive 10% F&F discount. Please get in touch if you would like to optimise this or connect with the team there! #OptimumStrategicCommunications #OnHelix24
-
-
In the latest episode of #OptimumTV, 4SC AG’s CEO Jason Loveridge talks about the company’s plans to bring its drug resminostat to market for the treatment of CTCL, a type of non-Hodgkin’s lymphoma that affects the skin.
-
From an investment in AI-based solutions for sustainable #agriculture to new data from hepatocellular carcinoma therapy, here’s what Optimum and its clients have been up to this week! #OptimumStrategicCommunications #Biotech #LifeSciences
Congratulations to Verona Pharma on securing FDA approval of COPD maintenance therapy Ohtuvayre (ensifentrine)
Optimum Strategic Communications on LinkedIn
-
The death cap mushroom is feared throughout the world because of the deadly toxin it contains, amanitin. But our client Heidelberg Pharma AG thinks amanitin could be used to fight cancer - find out more in our latest feature. #cancer #pharma #mushrooms
Death cap poison: the latest weapon in the fight against cancer
Optimum Strategic Communications on LinkedIn